Peace, James H.
McKee, Hayley J.
Kopczynski, Casey C.
Funding for this research was provided by:
Aerie Pharmaceuticals, Inc
Article History
Received: 22 October 2020
Accepted: 11 November 2020
First Online: 26 November 2020
Funding
: Aerie Pharmaceuticals, Inc. (Durham, NC), funded this study. Aerie Pharmaceuticals, Inc. also funded the journal’s Rapid Service Fees.
: Andrew J. Horgan, PhD, of BioScience Communications (New York, NY) provided medical writing and editorial services, activity that was also funded by Aerie Pharmaceuticals, Inc.
: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
: Data from this study were presented at the 2017 ARVO Annual Meeting, 7–11 May 2017, Baltimore, MD.
: James H. Peace reports consulting work with Aerie Pharmaceuticals, Alcon, and Allergan. Hayley J. McKee and Casey C. Kopczynski are employees of Aerie Pharmaceuticals, Inc.
: Institutional ethics approval was obtained from Schulman Institutional Review Board (IRB# 201604624). The study was conducted in accordance with institutional review board regulations; US Code of Federal Regulations, Title 21; International Conference on Harmonization-Consolidated Good Clinical Practices Guideline (E6); standard operating procedures of the sponsor and any vendors participating in the conduct of the study; and the ethical principles that have their origin in the Declaration of Helsinki. An approved informed consent procedure had to take place before any study-specific procedures were initiated.
: Datasets generated during and/or analyzed during the current study are available at ExternalRef removed.